EUVIMEDEUVIMED entdecken
Crossref

Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment

Alexander Keenan, Chiara Whichello iD, Hoa H Le, David M Kern, Gabriela S Fernandez, Vicky Turner, Anup Das, Matthew Quaife, Amy Perrin Ross

The Patient - Patient-Centered Outcomes Research · 2024

DOI: 10.1007/s40271-024-00699-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Patient - Patient-Centered Outcomes Research, 2024. Verfasst von Alexander Keenan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. akeenan1@its.jnj.com. Hauptthemen laut MEDLINE: Patient Preference, Sphingosine 1 Phosphate Receptor Modulators, Multiple Sclerosis, Relapsing-Remitting, Fingolimod Hydrochloride. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Janssen Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient PreferenceSphingosine 1 Phosphate Receptor ModulatorsMultiple Sclerosis, Relapsing-RemittingFingolimod HydrochlorideBenzyl CompoundsHumansMaleFemaleAdultMiddle AgedOxadiazolesAzetidinesBiphenyl CompoundsImmunosuppressive AgentsChoice BehaviorIndansSphingosine-1-Phosphate ReceptorsYoung AdultThiazoles

Substanzen

ozanimodSphingosine 1 Phosphate Receptor ModulatorsponesimodsiponimodFingolimod HydrochlorideBenzyl CompoundsOxadiazolesAzetidinesBiphenyl CompoundsImmunosuppressive Agents

Autor:innen und Institutionen

  • Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. akeenan1@its.jnj.com.
  • Evidera, The Ark, 201 Talgarth Rd, London, W6 8BJ, UK.
  • Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.
  • Janssen Research and Development, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
  • Evidera, 7101 Wisconsin Ave # 1400, Bethesda, MD, 20814, USA.
  • Loyola University Chicago, 2160 S 1st Ave, Maywood, IL, 60153, USA.

ORCID-Profile: Chiara Whichello

Förderung

  • Janssen Pharmaceuticals

Zitieren

APA

Keenan, A., Whichello, C., Le, H. H., Kern, D. M., Fernandez, G. S., Turner, V., Das, A., Quaife, M., & Ross, A. P. (2024). Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment. The Patient - Patient-Centered Outcomes Research. https://doi.org/10.1007/s40271-024-00699-2

Vancouver

Keenan A, Whichello C, Le HH, Kern DM, Fernandez GS, Turner V, et al. Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment. The Patient - Patient-Centered Outcomes Research. 2024. doi:10.1007/s40271-024-00699-2

BibTeX
@article{Keenan2024,
  author = {Keenan, Alexander and Whichello, Chiara and Le, Hoa H and Kern, David M and Fernandez, Gabriela S and Turner, Vicky and Das, Anup and Quaife, Matthew and Ross, Amy Perrin},
  title = {Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment},
  journal = {The Patient - Patient-Centered Outcomes Research},
  year = {2024},
  doi = {10.1007/s40271-024-00699-2}
}
Kostenlos starten →